Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 4
1963 1
1964 1
1965 1
1966 2
1967 1
1968 9
1969 5
1971 2
1973 4
1974 3
1975 2
1976 3
1977 3
1978 3
1979 2
1980 5
1981 7
1982 4
1983 12
1984 11
1985 19
1986 21
1987 25
1988 35
1989 27
1990 33
1991 23
1992 25
1993 22
1994 29
1995 16
1996 31
1997 33
1998 37
1999 33
2000 40
2001 33
2002 33
2003 39
2004 54
2005 38
2006 43
2007 47
2008 65
2009 54
2010 54
2011 55
2012 55
2013 71
2014 56
2015 46
2016 49
2017 64
2018 77
2019 53
2020 65
2021 51
Text availability
Article attribute
Article type
Publication date

Search Results

1,497 results
Results by year
Filters applied: . Clear all
Page 1
Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018.
Okamoto N, Yokota S, Takei S, Okura Y, Kubota T, Shimizu M, Nozawa T, Iwata N, Umebayashi H, Kinjo N, Kunishima T, Yasumura J, Mori M. Okamoto N, et al. Among authors: yokota s. Mod Rheumatol. 2019 Jan;29(1):41-59. doi: 10.1080/14397595.2018.1514724. Epub 2018 Oct 29. Mod Rheumatol. 2019. PMID: 30126298
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N. Nakaoka Y, et al. Among authors: yokota s. Ann Rheum Dis. 2018 Mar;77(3):348-354. doi: 10.1136/annrheumdis-2017-211878. Epub 2017 Nov 30. Ann Rheum Dis. 2018. PMID: 29191819 Free PMC article. Clinical Trial.
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
Nakaoka Y, Isobe M, Tanaka Y, Ishii T, Ooka S, Niiro H, Tamura N, Banno S, Yoshifuji H, Sakata Y, Kawakami A, Atsumi T, Furuta S, Kohsaka H, Suzuki K, Hara R, Maejima Y, Tsukamoto H, Takasaki Y, Yamashita K, Okada N, Yamakido S, Takei S, Yokota S, Nishimoto N. Nakaoka Y, et al. Among authors: yokota s. Rheumatology (Oxford). 2020 Sep 1;59(9):2427-2434. doi: 10.1093/rheumatology/kez630. Rheumatology (Oxford). 2020. PMID: 31951279 Free PMC article. Clinical Trial.
Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.
Osa A, Uenami T, Koyama S, Fujimoto K, Okuzaki D, Takimoto T, Hirata H, Yano Y, Yokota S, Kinehara Y, Naito Y, Otsuka T, Kanazu M, Kuroyama M, Hamaguchi M, Koba T, Futami Y, Ishijima M, Suga Y, Akazawa Y, Machiyama H, Iwahori K, Takamatsu H, Nagatomo I, Takeda Y, Kida H, Akbay EA, Hammerman PS, Wong KK, Dranoff G, Mori M, Kijima T, Kumanogoh A. Osa A, et al. Among authors: yokota s. JCI Insight. 2018 Oct 4;3(19):e59125. doi: 10.1172/jci.insight.59125. JCI Insight. 2018. PMID: 30282824 Free PMC article.
Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.
Yamamoto N, Nakagawa K, Nishimura Y, Tsujino K, Satouchi M, Kudo S, Hida T, Kawahara M, Takeda K, Katakami N, Sawa T, Yokota S, Seto T, Imamura F, Saka H, Iwamoto Y, Semba H, Chiba Y, Uejima H, Fukuoka M. Yamamoto N, et al. Among authors: yokota s. J Clin Oncol. 2010 Aug 10;28(23):3739-45. doi: 10.1200/JCO.2009.24.5050. Epub 2010 Jul 12. J Clin Oncol. 2010. PMID: 20625120 Clinical Trial.
Multiple cardiac complications associated with collagen disease.
Suzuki M, Tanaka H, Yokota S, Hara T, Ueda Y, Hirata KI. Suzuki M, et al. Among authors: yokota s. J Echocardiogr. 2020 Nov 19. doi: 10.1007/s12574-020-00504-7. Online ahead of print. J Echocardiogr. 2020. PMID: 33215326 No abstract available.
1,497 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page